Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aminoglycoside nephrotoxicity and its predictability

K Sethi, L H Diamond

    Nephron
    |January 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Urinary biomarkers like beta 2-microglobulin (beta 2m) and specific enzymes can predict kidney damage from aminoglycosides. These lab tests detect nephrotoxicity earlier than traditional serum creatinine monitoring.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Analysis of stability for nut yield and ancillary traits in cashew (Anacardium occidentale L.).

    Scientific reports·2024
    Same author

    Laboratory Diasnosis of Small Pox.

    The Indian medical gazette·2017
    Same author

    The burden of non-motor symptoms in Parkinson's disease using a self-completed non-motor questionnaire: a simple grading system.

    Parkinsonism & related disorders·2015
    Same author

    Diagnostic value of the rapid assessment of postural instability in Parkinson's disease (RAPID) questionnaire.

    International journal of clinical practice·2012
    Same author

    Rapid assessment of postural instability in Parkinson's disease (RAPID): a pilot study.

    European journal of neurology·2010
    Same author

    International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease.

    Neurology·2009
    Same journal

    The Impact of High-Altitude Acclimatization on Frontal Lobe Executive Function: The Mediating Effect of Creatinine.

    Nephron·2026
    Same journal

    Expert Commentary of the Recent International Pediatric Nephrology Association IgA Vasculitis Nephritis Guidelines.

    Nephron·2026
    Same journal

    Acute effects of exercise on the nephron index under different conditions in middle-aged males - a preliminary study.

    Nephron·2026
    Same journal

    Lysozyme-Associated Nephropathy in Myeloid Neoplasms: A Clinicopathological and Mass Spectrometric Study of Two Cases.

    Nephron·2026
    Same journal

    Prevalence of COVID-19 Pneumonia and Clinical Characteristics in Hemodialysis Patients During the SARS-CoV-2 Omicron Pandemic.

    Nephron·2026
    Same journal

    Real-World Outcomes of Patients with Monoclonal Gammopathy of Renal Significance.

    Nephron·2026
    See all related articles

    Area of Science:

    • Nephrology
    • Clinical Biochemistry
    • Pharmacology

    Background:

    • Aminoglycosides are potent antibiotics but carry a risk of nephrotoxicity.
    • Early detection of kidney damage is crucial for patient management and preventing irreversible harm.

    Purpose of the Study:

    • To evaluate the utility of urinary beta 2-microglobulin (beta 2m) and proximal tubular enzymes as early markers of aminoglycoside-induced nephrotoxicity.
    • To compare the sensitivity of these laboratory markers with traditional clinical indicators like serum creatinine levels.

    Main Methods:

    • Serial urinary measurements of beta 2-microglobulin (beta 2m), N-acetyl-glucosaminidase, and beta-glucuronidase were performed in 37 patients receiving aminoglycosides.
    • Clinical nephrotoxicity was defined as a >20% rise in serum creatinine.

    Related Experiment Videos

  • Laboratory nephrotoxicity was defined as a two-fold increase in urinary beta 2m and enzyme levels.

    • Main Results:

    • Clinical nephrotoxicity was observed in 15 of 30 evaluable patients.
    • Laboratory markers confirmed nephrotoxicity in 11 of these 15 patients.
    • Three patients showed laboratory evidence of nephrotoxicity without a significant rise in serum creatinine.
    • Laboratory diagnosis of nephrotoxicity preceded significant serum creatinine elevation by 4.1–5.5 days.

    Conclusions:

    • Urinary beta 2-microglobulin and enzyme levels are sensitive predictors of aminoglycoside-induced nephrotoxicity.
    • These laboratory markers can detect kidney damage earlier than changes in serum creatinine.
    • Utilizing these biomarkers may allow for timely intervention to mitigate kidney injury.